News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
32 Results
Type
Article (4)
Press Release (28)
Section
Business (13)
Deals (1)
Drug Development (3)
News (16)
Tag
Alliances (5)
ALS (1)
Best Places to Work (1)
Cancer (8)
Cardiovascular disease (1)
Clinical research (9)
Collaboration (4)
C-suite (1)
Data (4)
Earnings (2)
Events (3)
Executive appointments (1)
Funding (2)
Gene therapy (1)
MASH (1)
Mergers & acquisitions (1)
Metabolic disorders (1)
Neurodegenerative disease (1)
Neuroscience (2)
People (6)
Phase 1 (5)
Phase 2 (6)
Phase 3 (1)
Pipeline (2)
Prostate cancer (4)
Radiopharmaceuticals (3)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (15)
2026 (1)
2025 (15)
2024 (3)
2023 (3)
2022 (2)
2020 (1)
2011 (2)
Location
Australia (16)
California (1)
Europe (6)
Indiana (3)
Massachusetts (4)
North Carolina (1)
Northern California (1)
United States (8)
32 Results for "advancell".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AdvanCell to participate in Jefferies Global Healthcare Conference 2025 in London
November 11, 2025
·
2 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
·
3 min read
Press Releases
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer
October 20, 2025
·
5 min read
Press Releases
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
December 3, 2025
·
4 min read
Press Releases
AdvanCell Appoints Philina Lee, PhD as Chief Executive Officer to Lead US Expansion and Drive Global Growth
November 18, 2025
·
4 min read
Press Releases
AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors
October 16, 2025
·
4 min read
Press Releases
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies
December 9, 2025
·
4 min read
Press Releases
AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25
September 29, 2025
·
3 min read
Press Releases
AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 2025
October 13, 2025
·
3 min read
Press Releases
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
February 3, 2025
·
5 min read
1 of 4
Next
